In the present study, we found that CHB promoted LOX-1+ PMN-MDSC expansion and activation in NPC survivors, and that LOX-1+ PMN-MDSCs may permit EBV immune tolerance. The gene discussed is OLR1; the disease is nasopharyngeal carcinoma.